Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Stem Cells and Antibodies in Drug Discovery Europe 2018

Stem Cells and Antibodies in Drug Discovery Europe 2018

Date: Thursday, 24 May 2018 - Friday, 25 May 2018
Location: Cambridge, UK


Keynote Speakers

Stephen Helliwell

Stephen Helliwell
Senior Investigator, Novartis Institutes for BioMedical Research

Matthew Daniels

Matthew Daniels
Wellcome Trust Intermediate Clinical Fellow, Honorary Consultant Cardiologist, University of Oxford

Robert Williams

Robert Williams
Chief Drug Development Scientist, Cancer Research UK

Gary Gintant

Gary Gintant
Research Fellow, Abbvie

David Hay

David Hay
Professor, University of Edinburgh

Paul French

Paul French
Professor, Department of Physics and Photonics Group, Imperial College London

Stefan Dubel

Stefan Dubel
Full Professor and Director, Technische Universität Braunschweig

Overview

Stem Cells and Antibodies in Drug Discovery 2018 and Antibodies in Drug Discovery 2018 is held co-located and concurrently with High-Content & Phenotypic Screening 2018 which explores the emerging trends and technologies impacting Drug Discovery, circa 2018.

Delegates and Exhibitors Receive Full Access to Both Conference Tracks and the Scientific Content and Presentations are Intertwined Between These Tracks

Stem Cells in Drug Discovery 2018: Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Antibodies in Drug Discovery 2018:
The focus is to explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics. Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research. If you work in antibody drug discovery research you will benefit from the expert knowledge of academic and industry leaders, whilst networking with the technology providers.

Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 14 May 2018

Agenda Topics

  • 3D-Cell Based Models
  • Antibodies for New Targets
  • Antibody Drug Conjugates (ADCs)
  • Antibody Screening
  • Humanized Single Domain Antibodies for Research and Therapeutic Applications
  • iPSC-derived Cells for Toxicity Testing & Screening
  • Monoclonal Antibodies
  • Scale Up and Quality Control
  • Screening Technologies, Instrumentation and Reagents
  • Stem Cells in Drug Discovery and Toxicity Screening
  • Targeting Ion Channels with Biologics

Sponsorship and Exhibition Opportunities

Exhibition Team,
exhibitors@selectbio.com
+44 (0) 1206 501654

Confirmed Speakers to date

Louise Affleck, UK Team Leader, Cisbio Bioassays
Ofer Binah, Professor, Department of Physiology, Biophysics and Systems Biology, Ruth & Bruce Rappaport Faculty of Medicine, Technion – Israel Institute of Technology
Hugh Byrne, Professor, Dublin Institute of Technology
Jacqueline Chuah, Lab Officer, Institute of Bioengineering and Nanotechnology, A*Star
Maciej Daniszewski, PhD Student, University of Melbourne
Nicholas Hannan, Assistant Professor, University of Nottingham
Ben Haworth, Cellular Imaging Application Specialist, GE Life Sciences
Peter Horvath, Finnish Distinguished Professor, Fellow FIMM Helsinki and Group Leader, Hungarian Academia of Sciences
Simon Hufton, Section Head Molecular Immunology, National Institute for Biological Standard and Control (NIBSC)
Hua Rong Lu, Senior Principal Scientist, Discovery Sciences, Janssen Pharmaceutical NV
Peter O'Brien, Head of Clinical Pathology, University College Dublin
Alice Pébay, Associate Professor, Principal Research Fellow, University of Melbourne & Centre for Eye Research Australia
Sanjay Sinha, BHF Senior Research Fellow, University of Cambridge
Masatoshi Suzuki, Associate Professor, Department of Comparative Biosciences and Stem Cell & Regenerative Medicine Center, University of Wisconsin-Madison
E. Sally Ward, Professor, Texas A&M University Health Science Center
Joanne Young, Senior Scientist, CYTOO SA


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-05-24 00:00:002018-05-25 00:00:00Europe/LondonStem Cells and Antibodies in Drug Discovery Europe 2018Stem Cells and Antibodies in Drug Discovery Europe 2018 in Cambridge, UKCambridge, UKSELECTBIOenquiries@selectbiosciences.com